Education
About Us
Working with TipRanks
Follow Us
Evolent Health (EVH)
NYSE:EVH
EVH Stock Chart & Stats
$6.00
<$0.01(0.08%)
At close: 4:00 PM EST
$6.00
<$0.01(0.08%)
Day’s Range― - ―
52-Week Range$5.98 - $15.56
Previous CloseN/A
Volume268.11K
Average Volume (3M)2.48M
Market Cap
$746.18M
Enterprise ValueN/A
Total Cash (Recent Filing)$151.00M
Total Debt (Recent Filing)$204.74M
Price to Earnings (P/E)―
Beta-0.05
Next Earnings
Feb 25, 2026EPS Estimate
0.07Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding117,508,720
10 Day Avg. Volume2,724,870
30 Day Avg. Volume2,477,074
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$16.13Price Target Upside168.83% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Debt ManagementThe sale of Evolvent Care Partners helps reduce debt, providing financial flexibility for Evolent Health Inc.
Earnings PerformanceThe company outperformed expectations in Q3 results as cost trends remain under control.
Revenue GrowthThe company emphasized the robust late-stage pipeline and record new sales, with more than $750 million in new contracted annual revenue.
Bears Say
EBITDA Growth RisksEBITDA growth in 2026 will be difficult if HIX subsidies are not extended.
Policy RisksPolicy-driven membership declines pose a substantial risk to 2026 EBITDA growth.
Revenue GuidanceRevenue guidance was lowered by $220M due to two PS delays, including a contract delay with AET.
Evolent Health News
EVH FAQ
What was Evolent Health’s price range in the past 12 months?
Evolent Health lowest stock price was $5.97 and its highest was $15.56 in the past 12 months.
What is Evolent Health’s market cap?
Evolent Health’s market cap is $746.18M.
When is Evolent Health’s upcoming earnings report date?
Evolent Health’s upcoming earnings report date is Feb 25, 2026 which is in 109 days.
How were Evolent Health’s earnings last quarter?
Evolent Health released its earnings results on Nov 06, 2025. The company reported $0.05 earnings per share for the quarter, missing the consensus estimate of $0.097 by -$0.047.
Is Evolent Health overvalued?
According to Wall Street analysts Evolent Health’s price is currently Undervalued.
Does Evolent Health pay dividends?
Evolent Health does not currently pay dividends.
What is Evolent Health’s EPS estimate?
Evolent Health’s EPS estimate is 0.07.
How many shares outstanding does Evolent Health have?
Evolent Health has 117,508,720 shares outstanding.
What happened to Evolent Health’s price movement after its last earnings report?
Evolent Health reported an EPS of $0.05 in its last earnings report, missing expectations of $0.097. Following the earnings report the stock price went down -17.333%.
Which hedge fund is a major shareholder of Evolent Health?
Currently, no hedge funds are holding shares in EVH
Evolent Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$16.13 (168.83% Upside)
$16.13 (168.83% Upside)
Blogger Sentiment
Neutral
EVH Sentiment 50%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 2.0M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▲ 0.2%
Last 30 Days ▼ 1.4%
Last 30 Days ▼ 1.4%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-75.77%
12-Months-Change
Fundamentals
Return on Equity
-13.38%
Trailing 12-Months
Asset Growth
-0.55%
Trailing 12-Months
Company Description
Evolent Health
Evolent Health (EVH) is a leading healthcare technology company that specializes in providing integrated solutions to health systems and payers. The company operates in the healthcare sector, focusing on value-based care models aimed at improving patient outcomes and reducing costs. Evolent Health offers a suite of services including care management, analytics, technology infrastructure, and population health management, enabling healthcare organizations to transition to value-based care while enhancing operational efficiencies.
EVH Company Deck
EVH Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Evolent's earnings call was largely positive, highlighting financial success and strategic growth through new contracts and partnerships. However, there are challenges related to potential membership reductions in exchange markets and uncertainties in the 2026 financial outlook.View all EVH earnings summariesEVH Stock 12 Month Forecast
Average Price Target
$16.13
▲(168.83% Upside)
Technical Analysis
Ownership Overview
2.20% Insiders
25.48% Mutual Funds
1.00% Other Institutional Investors
56.40% Public Companies and
Individual Investors